Leah Graybill
About Leah Graybill
Leah Graybill is the Director, Cell Therapy Supply Chain Product Lead at Bristol Myers Squibb in Seattle, Washington, with extensive experience in biotechnology and pharmaceutical supply chain management.
Current Role at Bristol Myers Squibb
Leah Graybill serves as the Director, Cell Therapy Supply Chain Product Lead at Bristol Myers Squibb in Seattle, Washington. In this role, she has been leading the Cell Therapy Supply Chain Product since November 2019. Her responsibilities likely include overseeing the supply chain for cell therapy products, ensuring the efficient and effective supply of critical components for treatment pipelines.
Past Experience at Juno Therapeutics
Leah Graybill worked at Juno Therapeutics, Inc. as the Associate Director, Vector Supply Chain Lead. During her tenure from 2018 to 2019, she was responsible for overseeing the vector supply chain, which involved coordinating the supply of vectors used in gene therapy processes.
Long-term Career at Amgen
Leah Graybill spent 19 years at Amgen, where she held the position of Sr. Manager, Development Supply Chain (Supply Chain Product Lead). Her extensive tenure from 1999 to 2018 allowed her to develop a deep understanding of supply chain management in the biotechnology and pharmaceutical sectors. Her role likely entailed overseeing the supply chain for development products and ensuring they met regulatory and operational standards.
Educational Background
Leah Graybill has a robust educational background in biochemistry and supply chain management. She earned a BS in Biochemistry from California Polytechnic State University-San Luis Obispo, attending from 1995 to 1999. Additionally, in 2010, she pursued further studies at California Lutheran University and CSU Channel Islands, each for 11 months.
Expertise in Biotechnology and Pharmaceutical Industries
With a career spanning over two decades, Leah Graybill possesses extensive experience in the biotechnology and pharmaceutical industries. Her expertise is particularly focused on supply chain management for cell therapy products. Her roles at Bristol Myers Squibb, Juno Therapeutics, and Amgen highlight her capabilities in leading supply chain initiatives and ensuring the efficient delivery of critical therapy components.
Professional Impact in Greater Seattle Area
Based in the Greater Seattle Area, Leah Graybill contributes significantly to the local biotech community. Her work at Bristol Myers Squibb and previous roles at Juno Therapeutics have positioned her as a key player in the region's burgeoning biotech industry, particularly in the field of cell therapy.